GAMMA Investing LLC Grows Stake in Integer Holdings Co. (NYSE:ITGR)

GAMMA Investing LLC lifted its stake in shares of Integer Holdings Co. (NYSE:ITGR) by 74.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 653 shares of the medical equipment provider’s stock after purchasing an additional 278 shares during the period. GAMMA Investing LLC’s holdings in Integer were worth $85,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. increased its stake in shares of Integer by 0.6% during the first quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock worth $446,428,000 after purchasing an additional 23,382 shares in the last quarter. Earnest Partners LLC increased its stake in shares of Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after purchasing an additional 37,340 shares in the last quarter. Congress Asset Management Co. MA increased its stake in shares of Integer by 7.5% during the first quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock worth $52,886,000 after purchasing an additional 31,736 shares in the last quarter. Driehaus Capital Management LLC increased its stake in shares of Integer by 62.5% during the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock worth $40,880,000 after purchasing an additional 135,750 shares in the last quarter. Finally, Tributary Capital Management LLC increased its stake in shares of Integer by 0.3% during the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock worth $33,168,000 after purchasing an additional 772 shares in the last quarter. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on ITGR shares. Truist Financial upped their price objective on shares of Integer from $145.00 to $150.00 and gave the company a “buy” rating in a research note on Monday. Citigroup upped their price objective on shares of Integer from $124.00 to $130.00 and gave the company a “neutral” rating in a research note on Tuesday, October 1st. Oppenheimer started coverage on shares of Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price objective for the company. Bank of America upped their price objective on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Finally, Benchmark reaffirmed a “buy” rating and set a $130.00 price objective on shares of Integer in a research note on Wednesday, October 2nd. One analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $138.00.

Insider Transactions at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the company’s stock in a transaction that occurred on Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now directly owns 2,280 shares in the company, valued at approximately $272,824.80. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Company insiders own 2.00% of the company’s stock.

Integer Stock Performance

NYSE:ITGR opened at $132.43 on Tuesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The firm has a market capitalization of $4.44 billion, a price-to-earnings ratio of 45.82, a PEG ratio of 1.86 and a beta of 1.08. The company’s 50-day moving average is $125.46 and its two-hundred day moving average is $120.24. Integer Holdings Co. has a 1-year low of $69.40 and a 1-year high of $132.68.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The company had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. During the same period in the previous year, the business posted $1.14 EPS. Integer’s revenue was up 9.0% on a year-over-year basis. Analysts forecast that Integer Holdings Co. will post 5.3 EPS for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.